Alcon Inc. header image

Alcon Inc.

ALC

Equity

ISIN CH0432492467 / Valor 43249246

SIX Swiss Exchange (2026-09-25)
CHF 53.30-0.04%

Alcon Inc.
UMushroom community rating:

star star star star star
4.25 12 votes No rating yet
NegativeNeutralPositive

About company

Alcon Inc. is a leading global eye care company specializing in the development, manufacturing, and distribution of a comprehensive range of ophthalmic products. The company operates through two main business segments: Surgical and Vision Care. In the Surgical segment, Alcon provides an extensive portfolio of products and technologies for cataract, retinal, and refractive surgeries, including advanced technology intraocular lenses (ATIOLs) and viscoelastic solutions. These products are designed to address various eye conditions such as cataracts, presbyopia, and astigmatism. In the Vision Care segment, Alcon is one of the largest manufacturers of contact lenses and lens care products, offering a wide array of daily disposable, reusable, and color-enhancing lenses. Additionally, the company provides ocular health products, including treatments for dry eye, contact lens care, ocular allergies, and redness relief. Alcon is committed to innovation and improving eye care accessibility, aiming to enhance the quality of life for individuals worldwide through its cutting-edge technologies and comprehensive product offerings.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-9.42%1Y
-25.0%3Y
-31.9%5Y

Performance

26.8%1Y
25.1%3Y
25.2%5Y

Volatility

Market cap

31029 M

Market cap (USD)

Daily traded volume (Shares)

1,119,779

Daily traded volume (Shares)

1 day high/low

77.3 / 76.52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.25

12 votes
Performance:
starstarstarstarstar
4.18
Innovation:
starstarstarstarstar
4.45
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
3.73
Eduard Hüsler
Switzerland, 16 Apr 2025
star star star star star
gute Beimischung
Simone Flückiger
Switzerland, 28 Mar 2025
star star star star star
Interessant
Anna Blattmann
Switzerland, 28 Mar 2025
star star star star star
Interessante Aktie

EQUITIES OF THE SAME SECTOR

Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.43%USD 4.13
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.30%CHF 82.55
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.39%CHF 360.40
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.08%USD 36.15
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%CHF 86.20
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%USD 10.94
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.25%EUR 0.98
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 99.51
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 5.70
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.79%CHF 10.46